Dr. Fathi and Dr. Tsoukas, from the University of Chicago, say that “while there are several therapeutic options (for HPV infection), no treatment has been proven to be superior in terms of clinical clearance or recurrence (of HPV symptoms).” (1) They also emphasize that “no current treatment completely eradicates the human papillomavirus virus (HPV).” (1)
Another study showed that HPV infections is very common. In fact, the study showed that most Americans are infected with one or more strains of the human papillomavirus (HPV) (2). Dr. Zhiheng Pei and colleagues from Langone Medical Center at New York University collected tissue samples from 103 participants. The sample were collected from the mouth, skin, genitals, and guts. Then, they examined the samples for the presence of HPV DNA. The results showed that 69% of the participants in the study were infected with one or more of the known 109 strains of HPV. Most of the positive samples, 61%, were collected the skin, 41% were collected from the vagina, 30% from the mouth, and 17% from the gut. Only 4 participants were infected with the high risk HPV 16 or HPV 18 strains. Dr. Yingfei Ma, who also worked on the study, said that “The HPV ‘community’ in healthy people is surprisingly more vast and complex than previously thought and much further monitoring and research is needed to determine how the various non-cancer-causing HPV genotypes interact with the cancer-causing strains, such as genotypes 16 and 18 (2).”
The CBCD recommends that people infected with the HPV take Gene-Eden-VIR or Novirin. The formula of these natural antiviral products was tested by Hanan Polansky and Edan Itzkovitz from the CBCD in two clinical studies that followed FDA guidelines. The studies showed that the Gene-Eden-VIR and Novirin formula is effective against the HPV and other viruses. The clinical studies were published in the peer reviewed, medical journal Pharmacology & Pharmacy, the first, in a special edition on Advances in Antiviral Drugs. Study authors wrote that, “individuals infected with the HPV…reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR.” (3) The study authors also wrote that, “we observed a statistically significant decrease in the severity, duration, and frequency of symptoms.” (3)
Gene-Eden-VIR and Novirin are natural antiviral dietary supplements. Their formula contains five natural ingredients: Selenium, Camellia Sinesis Extract, Quercetin, Cinnamomum Extract, and Licorice Extract. The first ingredient is a trace element, and the other four are plant extracts. Each ingredient and its dose was chosen through a scientific approach. Scientists at polyDNA, the company that invented and patented the formula, scanned thousands of scientific and medical papers published in various medical and scientific journals, and identified the safest and most effective natural ingredients against latent viruses. To date, Gene-Eden-VIR and Novirin are the only natural antiviral products on the market with published clinical studies that support their claims.
It should be noted that no FDA approved drugs against an HPV infection are available. Current surgical treatments only target HPV symptoms, such as genital warts and cervical dysplasia. These treatments include procedures, such as cryotherapy, conization, and the Loop Electrosurgical Excision Procedure (LEEP). (3) Local procedures against HPV symptoms, such as genital warts, use “liquid nitrogen, a surgical knife (scalpel), a carbon dioxide (CO2) laser, or electrical current to remove the abnormal growths caused by the HPV. These growths include cells that harbor the active virus. The procedures do not target cells with the latent virus. Since they do not remove the latent virus, these procedures only produce a temporary remission.” (3)
Reference:
About CBCD
About CBCD
The Center for the Biology of Chronic Disease (https://www.cbcd.net) is a not-for-profit tax-exempt organization under section 501(c) 3 of the IRS tax code. The center’s mission is to advance the research on the biology of chronic disease and to accelerate the discovery of a cure for these diseases. The CBCD first published Dr. Hanan Polansky’s highly acclaimed “Purple” book, entitled “Microcompetition with Foreign DNA and the Origin of Chronic Disease” in 2003. In this book, he explains how foreign DNA fragments can cause many major diseases. The book has been read by more than 5,000 scientists around the world, and has been reviewed in more than 20 leading scientific journals. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
